The story of Viagra and its influence on the pharmaceutical sector presents a challenging question regarding its continued attractiveness as an investment. Initially a blockbuster success, generating huge sums , generic competition has substantially eroded profit margins . While established pharmaceutical firms maintain patents on related therapies

The performance of companies tied to iconic drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the patent expiration in key territories has introduced substantial volatility. Investors are now facing the consequences of lower-cost